Purpose. Human serum albumin (HSA) was mildly oxidized by a metal–catalyzed oxidation system (MCO–HSA), chloramine–T (CT–HSA) or H2O2 (H2O2–HSA), and the effects of these treatments on the structural, drug–binding and esterase–like properties were studied.
Methods. Protein conformation was examined by calorimetric, chromatographic, electrophoretic and spectroscopic techniques. Drug binding was studied by ultrafiltration method, and esterase–like activity was determined using p–nitrophenyl acetate as a substrate.
Results. Far–UV and near–UV CD spectra indicated that significant structural changes had occured as the result of treatment with MCO–HSA and CT–HSA but not with H2O2–HSA. However, SDS–PAGE analysis does not provide precise information on gross conformational changes such as fragmentation, cross–linking and SDS–resistant polymerisation. The results of differential scanning calorimetry, the fluorescence of the hydrophobic probe 1,1–bis–4–anilino–naphthalene–5,5–sulfonic acid and the elution time from a hydrophobic HPLC column indicated that MCO–HSA and CT–HSA in particular, have a more open structure and a higher degree of exposure of hydrophobic areas than unoxidized HSA. In all cases, high–affinity binding of warfarin remained unchanged for all the oxidized HSAs. However, high–affinity binding of ketoprofen to CT–HSA and, especially, MCO–HSA was diminished. In addition, the esterase–like activity of these proteins were all decreased to the same low level.
Conclusions. Mild oxidation of HSA has no detectable effect on the binding of drugs to site I in subdomain IIA. In contrast, both the ligand binding property of site II and the esterase–like activity of oxidized HSAs are decreased, most probably due to conformational changes in subdomain IIIA.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
B. Halliwell. Albumin–an important extracellular antioxidant? Biochem. Pharmacol. 37:569–571 (1988).
T. Peters, Jr. All about Albumin: Biochemistry, Genetics, and Medical Applications, Academic Press, San Diego, 1996.
E. Bourdon, N. Loreau, and D. Blache. Glucose and free radicals impair the antioxidant properties of serum albumin. FASEB J. 13:233–244 (1999).
J. Iglesias, V. E. Abernethy, Z. Wang, W. Lieberthal, and J. S. K. Levine. Albumin is a major serum survival factor for renal tubular cells and macrophages through scavenging of ROS. Am. J. Physiol. 277:F711–722 (1999).
R. T. Dean, J. V. Hunt, A. J. Grant, Y. Yamamoto, and E. Niki. Free radical damage to proteins: The influence of the relative localization of radical generation, antioxidants, and target proteins. Free Rad. Biol. Med. 11:161–168 (1991).
C. T. Bishop, Z. Mirza, J. D. Crapo, and B. A. Freeman. Free radical damage to culture porcine aortic endothelial cells and lung fibroblasts: Modulation by culture conditions. In Vitro Cell. Dev. Biol. 21:229–236 (1985).
J. Z. Krezanoski and R. D. Houlsby. A comparison of new hydrogen peroxide disinfection systems. J. Am. Optom. Assoc. 59:193–197 (1988).
D. C. Carter and J. X. Ho. Structure of serum albumin. Adv. Protein Chem. 45:153–203 (1994).
S. Curry, H. Mandelkow, P. Brick, and N. Franks. Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites. Nat. Struct. Biol. 5:827–835 (1998).
M. K. Cha and I. H. Kim. Glutathione–linked thiol peroxidase activity of human serum albumin. Biochem. Biophys. Res. Commun. 222:619–625 (1996).
S. Era, K. Kuwata, H. Imai, K. Nakamura, T. Hayashi, and M. Sogami. Age–related change in redox state of human serum albumin. Biochim. Biophys. Acta 1247:12–16 (1995).
M. Soriani, D. Pietraforte, and M. Minetti. Antioxidant potential of anaerobic human plasma: role of serum albumin and thiols as scavengers of carbon radicals. Arch. Biochem. Biophys. 312:180–188 (1994).
E. Meucci, A. Mordente, and G. E. Martorana. Metal–catalyzed oxidation of human serum albumin: conformational and functional changes. J. Biol. Chem. 266:4692–4699 (1991).
B. Garner, P. K. Witting, A. R. Waldeck, J. K. Christison, M. Raftery, and R. Stocker. Oxidation of high density lipoproteins. I. Formation of methionine sulfoxide in apolipoproteins AI and AII is an early event that accompanies lipid peroxidation and can be enhanced by alpha–tocopherol. J. Biol. Chem. 273:6080–6087 (1998).
J. W. Finch, R. K. Crouch, D. R. Knapp, and K. L. Schey. Mass spectrometric identification of modifications to human serum albumin treated with hydrogen peroxide. Arch. Biochem. Biophys. 305:595–599 (1993).
G. Sudlow, D. J. Birkett, and D. N. Wade. The characterization of two specific drug binding sites on human serum albumin. Mol. Pharmacol. 11:824–832 (1975).
H. Watanabe, S. Tanase, K. Nakajou, T. Maruyama, U. Kragh–Hansen, and M. Otagiri. Role of Arg–410 and Tyr–411 in human serum albumin for ligand binding and esterase–like activity. Biochem. J. 349:813–819 (2000).
R. F. Chen. Removal of fatty acids from serum albumin by charcoal treatment. J. Biol. Chem. 242:173–181 (1967).
I. Climent, L. Tsai, and R. L. Levine. Derivatization of γ–glutamyl semialdehyde residues in oxidized proteins by fluorescein–amine. Anal. Biochem. 182:226–232 (1989).
P. G. Pande, R. V. Nellore, and H. R. Bhagat. Optimization and validation of analytical conditions for bovine serum albumin using capillary electrophoresis. Anal. Biochem. 204:103–106 (1992).
T. Zor and Z. Selinger. Linearization of the Bradford protein assay increases its sensitivity: theoretical and experimental studies. Anal. Biochem. 236:302–308 (1996).
H. Schagger and G. Von Jagow. Tricine–sodium dodecyl sulfate–polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166:368–379 (1987).
K. Takabayashi, T. Imada, Y. Saito, and Y. Inada. Coupling between fatty acid binding and sulfhydryl oxidation in bovine serum albumin. Eur. J. Biochem. 136:291–295 (1983).
P. M. Horowitz, S. Hua, and D. L. Gibbons. Hydrophobic surfaces that are hidden in chaperonin Cpn60 can be exposed by formation of assembly–competent monomers or by ionic perturbation of the oligomer. J. Biol. Chem. 270:1535–1542 (1995).
P. J. Coussons, J. Jacoby, A. McKay, S. M. Kelly, N. C. Price, and J. V. Hunt. Glucose modification of human serum albumin: A structural study. Free Radic. Biol. Med. 22:1217–1227 (1997).
V. T. G. Chuang, A. Kuniyasu, H. Nakayama, Y. Matsushita, S. Hirono, and M. Otagiri. Helix 6 of subdomain IIIA of human serum albumin is the region primarily photolabeled by ketoprofen, an arylpropionic acid NSAID containing a benzophenone moiety. Biochim. Biophys. Acta 1434:18–30 (1999).
M. H. Rahman, K. Yamasaki, Y. H. Shin, C. C. Lin, and M. Otagiri. Characterization of high affinity binding sites of non–steroidal anti–inflammatory drugs with respect to site–specific probes on human serum albumin. Biol. Pharm. Bull. 16:1169–1174 (1993).
A. Amici, R. L. Levine, L. Tsai, and E. R. Stadtman. Conversion of amino acid residues in proteins and amino acid homopolymers to carbonyl derivatives by metal–catalyzed oxidation reactions. J. Biol. Chem. 264:3341–3346 (1989).
K. J. Fehske, W. E. Muller, U. Wollert, and L. M. Velden. The lone tryptophan residue of human serum albumin as part of the specific warfarin binding site. Binding of dicoumarol to the warfarin, indole and benzodiazepine binding sites. Mol. Pharmacol. 16:778–789 (1979).
About this article
Cite this article
Anraku, M., Yamasaki, K., Maruyama, T. et al. Effect of Oxidative Stress on the Structure and Function of Human Serum Albumin. Pharm Res 18, 632–639 (2001). https://doi.org/10.1023/A:1011029226072
- human serum albumin
- oxidative stress
- structural changes
- warfarin binding
- ketoprofen binding
- esterase–like activity